Alpha DNA Investment Management’s Procter & Gamble PG Stock Holding History

Alpha DNA Investment Management’s Portfolio PG Stock Details PG Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-11,942	Closed	-$2.07M	–	245
2024 Q3	$2.07M	Buy	11,942 +6,023	+102%	+$1.02M	0.77%	23
2024 Q2	$976K	Sell	5,919 -437	-7%	-$71.4K	0.38%	51
2024 Q1	$1.03M	Sell	6,356 -5,107	-45%	-$801K	0.38%	45
2023 Q4	$1.68M	Sell	11,463 -416	-4%	-$61.6K	0.66%	31
2023 Q3	$1.73M	Buy	+11,879	New	+$1.81M	0.71%	29
2021 Q2	–	Sell	-21	Closed	-$2K	–	488
2021 Q1	$2K	Hold	21	–	–	﹤0.01%	576
2020 Q4	$2K	Buy	+21	New	+$2.94K	﹤0.01%	474

Other funds holding PG

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Koshinski Asset Management Decatur, Illinois $1.88B AUM 29.07% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Alpha DNA Investment Management's PG Position: Q4 2024 in Review

Alpha DNA Investment Management sold out of Procter & Gamble (PG) in Q4 2024, closing a stake of 11,942 shares — an estimated $2.07M sold.

Alpha DNA Investment Management first reported a position in PG in Q4 2020 and held it in 7 quarters. The position peaked at $2.07M in Q3 2024. 4,003 funds tracked by Wall St. Rank hold PG as of Q4 2024.

Alpha DNA Investment Management reported no remaining Procter & Gamble position as of Q4 2024 after selling out during the quarter.
Alpha DNA Investment Management sold 11,942 Procter & Gamble shares in Q4 2024, an estimated $2.07M.
Alpha DNA Investment Management first reported a position in Procter & Gamble in Q4 2020 and held it in 7 quarters.
Alpha DNA Investment Management's Procter & Gamble position peaked at $2.07M in Q3 2024.
4,003 funds tracked by Wall St. Rank held Procter & Gamble as of Q4 2024.

Based on Alpha DNA Investment Management's 13F filing for Q4 2024, filed 13 Feb 2025.